OTC:ZVSA | Cash Flow Statement | ZyVersa Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2021-06-30 to 2026-03-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-03-31-$1.79M-$799,118.00$1M
2025-12-31-$678,572.00-$413,689.00-$12,511.00
2025-09-30-$19.81M
2025-06-30-$2.21M
2025-03-31-$2.26M-$1.77M$1.85M
2024-12-31-$1.42M-$1.21M$2.62M
2024-09-30-$2.4M
2024-06-30-$2.76M
2024-03-31-$2.83M-$3.78M$2.67M
2023-12-31-$13.34M-$2.79M$4.35M
2023-09-30-$2.9M
2023-06-30-$78.51M
2023-03-31-$3.54M-$4.59M-$34,674.00
2022-12-12-$12.25M-$779,816.00-$832,922.00
2022-09-30-$679,087.00
2022-06-30-$393,639.00
2022-03-31-$720,006.00-$98,165.00-$2.7M$2.7M
2021-09-30-$174.00
2021-06-30-$789.00-$48,075.00$750,557.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$24.95M-$5.11M$3.69M
2024-12-31-$9.41M-$7.52M$5.91M
2023-12-31-$98.3M-$8.72M$5.96M
2022-12-12-$14.05M-$1.49M$1.87M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.